Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wayne Moore

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
Diabetes Care|April 15, 2024
Early Metabolic Endpoints Identify Persistent Treatment Efficacy in Recent-Onset Type 1 Diabetes Immunotherapy TrialsLaura M Jacobsen, David Cuthbertson, Brian N Bundy, et al.
Acta Neuropathologica Communications|July 5, 2023
Mechanisms of metabolic stress induced cell death of human oligodendrocytes: relevance for progressive multiple sclerosisMilton Guilherme Forestieri Fernandes, Abdulshakour Mohammadnia, Florian Pernin, et al.
Pediatric Diabetes|April 30, 2025
Continuous Glucose Monitoring Provides Durable Glycemic Benefit in Adolescents and Young Adults with Type 1 Diabetes: 12-Month Follow-Up ResultsKellee M Miller, Colleen Bauza, Lauren G Kanapka, et al.
Brain : a Journal of Neurology|March 23, 2021
Deep grey matter injury in multiple sclerosis: a NAIMS consensus statementDaniel Ontaneda, Praneeta C Raza, Kedar R Mahajan, et al.
The New England Journal of Medicine|June 11, 2019
An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 DiabetesKevan C Herold, Brian N Bundy, S Alice Long, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|May 18, 2020
Imaging Mechanisms of Disease Progression in Multiple Sclerosis: Beyond Brain AtrophyFrancesca Bagnato, Susan A Gauthier, Cornelia Laule, et al.
Journal of Neuroscience Research|March 23, 2026
Age and Maturation Stage Linked Consequences of Fibrinogen on Human OligodendrogliaGabriela J Blaszczyk, Chao Weng, Abdulshakour Mohammadnia, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|August 30, 2008
MIFlowCyt: the minimum information about a Flow Cytometry ExperimentJamie A Lee, Josef Spidlen, Keith Boyce, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Diabetes Care|April 15, 2024
Early Metabolic Endpoints Identify Persistent Treatment Efficacy in Recent-Onset Type 1 Diabetes Immunotherapy TrialsLaura M Jacobsen, David Cuthbertson, Brian N Bundy, et al.
Acta Neuropathologica Communications|July 5, 2023
Mechanisms of metabolic stress induced cell death of human oligodendrocytes: relevance for progressive multiple sclerosisMilton Guilherme Forestieri Fernandes, Abdulshakour Mohammadnia, Florian Pernin, et al.
Pediatric Diabetes|April 30, 2025
Continuous Glucose Monitoring Provides Durable Glycemic Benefit in Adolescents and Young Adults with Type 1 Diabetes: 12-Month Follow-Up ResultsKellee M Miller, Colleen Bauza, Lauren G Kanapka, et al.
Brain : a Journal of Neurology|March 23, 2021
Deep grey matter injury in multiple sclerosis: a NAIMS consensus statementDaniel Ontaneda, Praneeta C Raza, Kedar R Mahajan, et al.
The New England Journal of Medicine|June 11, 2019
An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 DiabetesKevan C Herold, Brian N Bundy, S Alice Long, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|May 18, 2020
Imaging Mechanisms of Disease Progression in Multiple Sclerosis: Beyond Brain AtrophyFrancesca Bagnato, Susan A Gauthier, Cornelia Laule, et al.
Journal of Neuroscience Research|March 23, 2026
Age and Maturation Stage Linked Consequences of Fibrinogen on Human OligodendrogliaGabriela J Blaszczyk, Chao Weng, Abdulshakour Mohammadnia, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|August 30, 2008
MIFlowCyt: the minimum information about a Flow Cytometry ExperimentJamie A Lee, Josef Spidlen, Keith Boyce, et al.
Pageof 8